Plain-English translation of ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new investigational medication called , which is being developed specifically for advanced colorectal cancer. The medication will be combined with chemotherapy drugs that are already approved and commonly used to treat this cancer. Researchers want to find the right dose of this new medication that works best and is safe when paired with standard treatments.
Colorectal cancer that has spread to other parts of the body is difficult to treat, and doctors are always looking for new approaches to improve outcomes. This medication works in a new way, and early research suggests it might help fight the cancer when combined with treatments doctors already use.
You likely qualify if…
You likely don't qualify if…
You would attend regular visits at a hospital or clinic over approximately 6 years to receive intravenous infusions of the medication combined with standard chemotherapy. Throughout the study, you'll have frequent medical check-ups, blood tests, and imaging scans to see how the treatment is working and to monitor for any side effects. The study involves two phases: first, doctors will test increasing doses to find the right amount, then you may be randomly assigned to receive one of two optimized doses or standard treatment without the new medication.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States